These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28978885)

  • 41. Laparoscopic-assisted microwave ablation for hepatocellular carcinoma: safety and efficacy in comparison with radiofrequency ablation.
    Simo KA; Sereika SE; Newton KN; Gerber DA
    J Surg Oncol; 2011 Dec; 104(7):822-9. PubMed ID: 21520094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Percutaneous ablation of hepatocellular carcinoma in older patients in clinical practice].
    Romero Gutiérrez M; Ruano Díaz L; Muñoz López D; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; de la Cruz Pérez G; Gómez Rodríguez R
    Gastroenterol Hepatol; 2015 Feb; 38(2):54-61. PubMed ID: 25499846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A Case of Repeated Surgical Resections for Tumor Seeding of Hepatocellular Carcinoma after Radiofrequency Ablation].
    Fukuda Y; Asaoka T; Eguchi H; Iwagami Y; Yamada D; Noda T; Kawamoto K; Gotoh K; Kobayashi S; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2018 Feb; 45(2):342-344. PubMed ID: 29483441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single Hepatocellular Carcinoma approached by curative-intent treatment: A propensity score analysis comparing radiofrequency ablation and liver resection.
    Di Sandro S; Benuzzi L; Lauterio A; Botta F; De Carlis R; Najjar M; Centonze L; Danieli M; Pezzoli I; Rampoldi A; Bagnardi V; De Carlis L
    Eur J Surg Oncol; 2019 Sep; 45(9):1691-1699. PubMed ID: 31072620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiofrequency ablation plus devascularization is the preferred treatment of hepatocellular carcinoma with esophageal varices.
    Zhang K; Jiang L; Jia Z; Zhang Y; He R; Ding Z; Mu Y
    Dig Dis Sci; 2015 May; 60(5):1490-501. PubMed ID: 25431044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study.
    Giorgio A; Calisti G; Montesarchio L; Scognamiglio U; Matteucci P; Coppola C; Scarano F; Amendola F; Giorgio V
    Anticancer Res; 2014 Nov; 34(11):6785-90. PubMed ID: 25368292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lusutrombopag: A Review in Thrombocytopenia in Patients with Chronic Liver Disease Prior to a Scheduled Procedure.
    Shirley M; McCafferty EH; Blair HA
    Drugs; 2019 Oct; 79(15):1689-1695. PubMed ID: 31529283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Local recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Liao WJ; Shi M; Chen JZ; Li AM
    World J Gastroenterol; 2010 Oct; 16(40):5135-8. PubMed ID: 20976853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma.
    Takada Y; Kurata M; Ohkohchi N
    Int J Clin Oncol; 2003 Oct; 8(5):332-5. PubMed ID: 14586761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver.
    Vivarelli M; Guglielmi A; Ruzzenente A; Cucchetti A; Bellusci R; Cordiano C; Cavallari A
    Ann Surg; 2004 Jul; 240(1):102-7. PubMed ID: 15213625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
    Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
    Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The short-term efficacy of no-touch radiofrequency ablation in treating cirrhosis-based small hepatocellular carcinoma.
    Chai Y; Li K; Zhang C; Chen S; Ma K
    BMC Cancer; 2019 May; 19(1):497. PubMed ID: 31133001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC.
    Hocquelet A; Aubé C; Rode A; Cartier V; Sutter O; Manichon AF; Boursier J; N'kontchou G; Merle P; Blanc JF; Trillaud H; Seror O
    J Hepatol; 2017 Jan; 66(1):67-74. PubMed ID: 27422750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Percutaneous transcatheter embolisation of active haemorrhage following radiofrequency ablation of hepatocellular carcinoma.
    Dmytriw AA; Rivers-Bowerman MD; Woodley-Cook J
    BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27229748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
    Cheung TT; Ng KK; Poon RT; Fan ST
    J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma.
    Spolverato G; Vitale A; Ejaz A; Kim Y; Maithel SK; Cosgrove DP; Pawlik TM
    World J Surg; 2015 Jun; 39(6):1474-84. PubMed ID: 25665675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term Favorable Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma as an Initial Treatment: A Single-center Experience Over a 10-Year Period.
    Tsukamoto M; Yamashita YI; Imai K; Umezaki N; Yamao T; Kaida T; Mima K; Nakagawa S; Hashimoto D; Chikamoto A; Ishiko T; Baba H
    Anticancer Res; 2018 Feb; 38(2):1047-1052. PubMed ID: 29374739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma.
    Machi J; Bueno RS; Wong LL
    World J Surg; 2005 Nov; 29(11):1364-73. PubMed ID: 16240062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.